We are supported by a prestigious group of investors with global strategic vision. We raised $2.5 million in our Series A round of financing in Q1 2002.  Our investors included Critical Technology Ventures, Biotech Healthcare Partners, Mitsui & Co., Mitsui Knowledge Industry, Fujitsu Kyushu System, Aozora Bank, Yasuda Enterprise Investment, Teramecs, and Wilson Sonsini Goodrich & Rosati.

In Q4 2003 we raised $4.0 million in our Series B round.  The financing was led by Innovation Engine, a major Series A investor through its Critical Technology Fund, and included UFJ Capital, Trans Science, Japan Asia Investment Company (JAIC), and Tomy Digital Biology.